[go: up one dir, main page]

Wilson et al., 1981 - Google Patents

Intercalating drugs: DNA binding and molecular pharmacology

Wilson et al., 1981

Document ID
8898953787915073028
Author
Wilson W
Jones R
Publication year
Publication venue
Advances in Pharmacology

External Links

Snippet

Publisher Summary This chapter discusses the intercalating drugs. There are many drug molecules containing planar aromatic ring systems which can be inserted between base pairs of DNA in a process called intercalation. This interaction can lead to inhibition of DNA …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the means of detection
    • C12Q1/6818—Hybridisation assays characterised by the means of detection involving interaction of at least two labels, e.g. resonant energy transfer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid

Similar Documents

Publication Publication Date Title
Wilson et al. Intercalating drugs: DNA binding and molecular pharmacology
Adams et al. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino) ethyl] acridine-4-carboxamide bound to the DNA hexanucleotide d (CGTACG) 2
Lacourciere et al. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy
Mergny et al. Fluorescence energy transfer as a probe for nucleic acid structures and sequences
Fourmy et al. Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA
Franke et al. Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy
Dunham et al. Solution structure of a DNA duplex containing a nitroxide spin-labeled platinum d (GpG) intrastrand cross-link refined with NMR-derived long-range electron− proton distance restraints
Green et al. Aptamers as reagents for high-throughput screening
Isaksson et al. Single-stranded adenine-rich DNA and RNA retain structural characteristics of their respective double-stranded conformations and show directional differences in stacking pattern
WO2000047774A1 (en) Aptamers as reagents for high throughput screening
US20130210903A1 (en) Aptamers to glycoprotein vi
Gerland et al. Synthesis of homo-and heterofunctionalized glycoclusters and binding to Pseudomonas aeruginosa lectins PA-IL and PA-IIL
He et al. Selective targeting of guanine-vacancy-bearing G-quadruplexes by G-quartet complementation and stabilization with a guanine–peptide conjugate
Ranjan et al. Aminoglycoside binding to Oxytricha nova telomeric DNA
Han et al. Sequence specific recognition of ligand-DNA complexes studied by NMR
Krishnamoorthy et al. Stopped-flow kinetic analysis of the interaction of anthraquinone anticancer drugs with calf thymus DNA, poly [d (GC)]. cntdot. poly [d (GC)], and poly [d (AT)]. cntdot. poly [d (AT)]
Ano et al. Retro Models of Pt Anticancer Drug DNA Adducts: Chirality-Controlling Chelate Ligand Restriction of Guanine Dynamic Motion in (2, 2 ‘-Bipiperidine) PtG2 Complexes (G= Guanine Derivative)
Esquiaqui et al. Conformational flexibility and dynamics of the internal loop and helical regions of the kink–Turn Motif in the glycine riboswitch by site-directed spin-labeling
Astakhova et al. Novel (phenylethynyl) pyrene–LNA constructs for fluorescence SNP sensing in polymorphic nucleic acid targets
Kelly et al. Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem–loop RNAs and their implications for functional cellular assays
Alkhamis et al. Comparison of aptamer signaling mechanisms reveals disparities in sensor response and strategies to eliminate false signals
Wadkins et al. Thermodynamics of the interactions of m-AMSA and o-AMSA with nucleic acids: influence of ionic strength and DNA base composition
R Kore et al. Click chemistry based functionalizations of nucleoside, nucleotide and nucleic acids
Hurley et al. Molecular aspects of the interaction of (+)-CC-1065 with DNA
AU767490B2 (en) Method for quantitating oligonucleotides